Home / Resources / Articles / SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy

SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy

Aug 14, 2015
 

Reconsidering potential surgical option to treat severe obesity…

Laparoscopic sleeve gastrectomy (LSG) is a very common and efficient bariatric procedure used among young patients for weight loss. However, not much information is known about its long-term effects on obesity-related comorbidities.

A cohort study using a retrospective analysis of a prospective cohort was conducted to investigate the long-term effects of LSG on weight loss, diabetes, hypertension, dyslipidemia, and hyperuricemia. Main outcomes and measures included excess weight loss, obesity-related comorbidities, and partial and complete remission at 1, 3, and 5 years of follow-up.

Data was collected from a total of 443 LSGs performed between April 2006 and February 2013. The percentages of excess weight loss was 77%, 70%, and 56% at years 1, 3, and 5, respectively; complete remission of diabetes was maintained in 51%, 38%, and 20%, respectively, and remission of hypertension was maintained in 46%, 48%, and 46%, respectively.

The decrease of low-density lipoprotein cholesterol level was significant only at 1 year (P = .04) and 3 years (P = .04) and the changes in total cholesterol level were not statistically significant.

The results of this study confirm that there is a significant weight regain and a decrease in remission rates of diabetes and other comorbidities over time with long-term use of LSG.

Practice Pearls:

  • The percentages of excess weight loss with long-term use of LSGs was 77%, 70%, and 56% at years 1, 3, and 5, respectively; complete remission of diabetes was maintained in 51%, 38%, and 20%, respectively, and remission of hypertension was maintained in 46%, 48%, and 46%, respectively.
  • The decrease of low-density lipoprotein cholesterol level was significant only at 1 year (P = .04) and 3 years (P = .04) and the changes in total cholesterol level were not statistically significant.
  • The results of this study confirms that there is a significant weight regain and a decrease in remission rates of diabetes and other comorbidities over time with long-term use of LSG.

Golomb I, Ben david M, Glass A, Kolitz T, Keidar A. Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy. JAMA Surgery. 2015.